What's New In FDA's Latest Cell And Gene Therapy Guidance
On Sept. 20, the U.S. Food and Drug Administration issued draft guidance outlining how sponsors can utilize the FDA's expedited review pathways to facilitate development and streamlined review of cell and...To view the full article, register now.
Already a subscriber? Click here to view full article